NCT03907475 2026-03-18Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ TrialNational Cancer Institute (NCI)Phase 2 Recruiting115 enrolled
NCT05803382 2026-03-18Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable CancersNational Cancer Institute (NCI)Phase 1 Recruiting30 enrolled